Clinical Trial Update: The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cardiovascular effects after switching to aripiprazole in overweight/obese patients with schizophrenia; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hyperlipidemia
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole) (aripiprazole)

Snippet

Sponsor: University of Pittsburgh | Conditions: Overweight, Hyperlipidemia | Phase 4 | Status: COMPLETED